San Francisco Department of Public Health, 25 Van Ness Avenue, Ste. 500, San Francisco, CA, 94102, USA.
University of California San Francisco, 500 Parnassus Ave, San Francisco, CA, 94143, USA.
J Urban Health. 2022 Oct;99(5):865-872. doi: 10.1007/s11524-022-00663-1.
The rapid increase in fentanyl overdose deaths, particularly those also attributed to stimulants, has led to concerns about unintentional fentanyl exposure. Utilizing vital and medical record data, we identified overdose decedents from 2018 to 2021 in San Francisco who received care in the safety net system in the 3 years preceding death. Among 506 decedents, medical record evidence of pre-mortem opioid use was present for 48% of stimulant-only, 56% of stimulant-fentanyl, 65% of fentanyl-only, and 82% of non-fentanyl opioid decedents (p<0.001). Among stimulant-fentanyl decedents, an increase in 10 years of age (adjusted odds ratio (aOR) 0.74 [95% CI:0.59-0.94]) and race other than White or Black (aOR 0.36 [95% CI:0.15-0.87]) had lower odds of evidence of pre-mortem opioid use. While not conclusive, these findings raise the possibility that a significant proportion of fentanyl overdose decedents in San Francisco may have not intended to consume an opioid on the occasion of their death.
芬太尼过量死亡人数迅速增加,尤其是那些也归因于兴奋剂的死亡人数增加,这引起了人们对非故意芬太尼暴露的担忧。我们利用生命和医疗记录数据,确定了 2018 年至 2021 年在旧金山死亡的、在死亡前 3 年内接受安全网系统治疗的过量死亡者。在 506 名死者中,有 48%的仅使用兴奋剂者、56%的兴奋剂与芬太尼混合使用、65%的仅使用芬太尼者和 82%的非芬太尼类阿片类药物死者(p<0.001)存在生前使用阿片类药物的医疗记录证据。在芬太尼与兴奋剂混合使用的死者中,年龄增加 10 岁(调整后的优势比(aOR)为 0.74[95%可信区间:0.59-0.94])和种族不是白人或黑人(aOR 0.36[95%可信区间:0.15-0.87])的情况下,生前使用阿片类药物的可能性降低。尽管这些发现尚不能得出结论,但它们提出了一种可能性,即在旧金山的芬太尼过量死亡者中,相当一部分人可能并非故意在死亡时摄入阿片类药物。